HEALTHYWAY INC (02587) spent HK$429,400 on December 30th to repurchase 98,000 shares.
Health Road (02587) announced that on December 30, 2025, the company spent 429,400 Hong Kong dollars to repurchase 98,000 shares, with a repurchase price range of 4.38-4.4 Hong Kong dollars per share.
HEALTHYWAY INC (02587) announced on December 30, 2025, that the company will spend 429,400 Hong Kong dollars to repurchase 98,000 shares, with a repurchase price of 4.38-4.4 Hong Kong dollars per share.
Related Articles
KB LAMINATES (01888) appoints Rong Hai En as an independent non-executive director.
Shanghai Fosun Pharmaceutical (02196) subsidiary has initiated Phase I clinical trials for the integrated diagnosis and treatment project SRT-007 in China.
AAC TECH spent 1.3973 million Hong Kong dollars to repurchase 36,000 shares on December 30th.
KB LAMINATES (01888) appoints Rong Hai En as an independent non-executive director.
Shanghai Fosun Pharmaceutical (02196) subsidiary has initiated Phase I clinical trials for the integrated diagnosis and treatment project SRT-007 in China.
AAC TECH spent 1.3973 million Hong Kong dollars to repurchase 36,000 shares on December 30th.
